這項可行性隨機對照試驗將評估一項整合靜觀與運動的電子健康介入措施 eMindExCare 於香港接受積極治療的前列腺癌患者中的可接受性、可行性及初步效果。參加者將按 1:1 比例隨機分配至為期 8 週的 eMindExCare 介入組或加強健康教育注意力對照計劃。
適應症：Prostate Cancer、Sleep Disturbance、Fatigue、Physical Inactivity、Pain
收案條件
納入條件
- Diagnosed with prostate cancer, stage I, II, or III.
- Aged older than 18 years.
- Undergoing active treatment, including chemotherapy, radiotherapy, or hormone therapy, at Prince of Wales Hospital.
- Able to communicate and read Chinese.
- Has access to the Internet and a computer or tablet.
- Demonstrates clinically impaired sleep quality or insufficient physical activity as measured by ActiGraph. Clinically impaired sleep quality may include study-defined sleep disturbance criteria such as total sleep time less than 6.5 hours, sleep onset latency greater than 30 minutes, awakenings lasting greater than 5 minutes, or wake after sleep onset greater than 30 minutes.
排除條件
- Diagnosed with more than one primary cancer.
- Has metastatic disease.
- Has participated in a mindfulness programme.
- Is sufficiently physically active at the time of recruitment.
- Has a mental condition, World Health Organization/Eastern Cooperative Oncology Group performance status greater than 2, a physical disability that prevents participation in the intervention, or any other health problem that rules out regular physical activity as determined by the treating physician.
收案條件維持 ClinicalTrials.gov 原始英文登錄資料，實際收案資格以研究團隊的正式評估與受試者同意書為準。資料來源：ClinicalTrials.gov，每兩週自動更新，最後同步：2026年10月8日。